Simone Scagnoli

1.1k total citations
41 papers, 464 citations indexed

About

Simone Scagnoli is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Simone Scagnoli has authored 41 papers receiving a total of 464 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Oncology, 23 papers in Pulmonary and Respiratory Medicine and 8 papers in Cancer Research. Recurrent topics in Simone Scagnoli's work include Cancer Immunotherapy and Biomarkers (16 papers), Advanced Breast Cancer Therapies (12 papers) and Cancer Treatment and Pharmacology (7 papers). Simone Scagnoli is often cited by papers focused on Cancer Immunotherapy and Biomarkers (16 papers), Advanced Breast Cancer Therapies (12 papers) and Cancer Treatment and Pharmacology (7 papers). Simone Scagnoli collaborates with scholars based in Italy, Germany and United Kingdom. Simone Scagnoli's co-authors include Andrea Botticelli, Paolo Marchetti, Marianna Nuti, Ilaria Grazia Zizzari, Bruna Cerbelli, Silvia Mezi, Enrico Cortesi, Giulia Pomati, Lidia Strigari and Alain Gelibter and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Simone Scagnoli

35 papers receiving 462 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simone Scagnoli Italy 12 293 142 121 109 83 41 464
Wentao Tian China 7 226 0.8× 95 0.7× 98 0.8× 155 1.4× 78 0.9× 15 454
Yuji Nojima Japan 13 313 1.1× 212 1.5× 129 1.1× 55 0.5× 50 0.6× 26 506
Roland Eid Lebanon 11 242 0.8× 154 1.1× 54 0.4× 192 1.8× 81 1.0× 30 479
Tang Qing China 3 200 0.7× 63 0.4× 110 0.9× 107 1.0× 41 0.5× 5 368
Koji Fujieda Japan 3 269 0.9× 48 0.3× 209 1.7× 77 0.7× 47 0.6× 3 403
Philippe Huget Belgium 6 256 0.9× 51 0.4× 97 0.8× 116 1.1× 79 1.0× 6 395
Yida Li China 14 230 0.8× 252 1.8× 40 0.3× 221 2.0× 155 1.9× 58 615
Haiyang Chen China 11 118 0.4× 111 0.8× 48 0.4× 192 1.8× 130 1.6× 44 400
Carmen Vallejo Spain 7 361 1.2× 74 0.5× 427 3.5× 70 0.6× 35 0.4× 15 651
Nick B. Tsavaris Greece 6 204 0.7× 68 0.5× 178 1.5× 69 0.6× 19 0.2× 9 410

Countries citing papers authored by Simone Scagnoli

Since Specialization
Citations

This map shows the geographic impact of Simone Scagnoli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simone Scagnoli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simone Scagnoli more than expected).

Fields of papers citing papers by Simone Scagnoli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simone Scagnoli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simone Scagnoli. The network helps show where Simone Scagnoli may publish in the future.

Co-authorship network of co-authors of Simone Scagnoli

This figure shows the co-authorship network connecting the top 25 collaborators of Simone Scagnoli. A scholar is included among the top collaborators of Simone Scagnoli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simone Scagnoli. Simone Scagnoli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Botticelli, Andrea, Simone Scagnoli, Valentina Guarneri, et al.. (2025). 15P The ROME trial: Personalized target therapy and immunotherapy in the breast cancer subgroup. ESMO Open. 10. 104569–104569. 1 indexed citations
3.
4.
Cirillo, Alessio, Ilaria Grazia Zizzari, Andrea Botticelli, et al.. (2023). Circulating CD137+ T Cell Levels Are Correlated with Response to Pembrolizumab Treatment in Advanced Head and Neck Cancer Patients. International Journal of Molecular Sciences. 24(8). 7114–7114. 9 indexed citations
5.
Mezi, Silvia, Andrea Botticelli, Simone Scagnoli, et al.. (2023). The Impact of Drug–Drug Interactions on the Toxicity Profile of Combined Treatment with BRAF and MEK Inhibitors in Patients with BRAF-Mutated Metastatic Melanoma. Cancers. 15(18). 4587–4587. 6 indexed citations
6.
Botticelli, Andrea, Simone Scagnoli, Pierfranco Conté, et al.. (2023). Abstract P6-10-09: Mutational landscape of breast cancer patients in ROME trial: preliminary results. Cancer Research. 83(5_Supplement). P6–10. 1 indexed citations
7.
Santini, Daniele, Andrea Botticelli, Antonio Galvano, et al.. (2023). Network approach in liquidomics landscape. Journal of Experimental & Clinical Cancer Research. 42(1). 193–193. 20 indexed citations
8.
Botticelli, Andrea, Simone Scagnoli, Simona Pisegna, et al.. (2022). 267P AB-ITALY: The impact of drug-drug interaction on abemaciclib treatment in Italian real world experience. Annals of Oncology. 33. S659–S660. 2 indexed citations
9.
Botticelli, Andrea, Agnese Fabbri, Michela Roberto, et al.. (2022). The Role of the CDK4/6 Inhibitor Ribociclib in Locally Advanced and Oligometastatic Hormone Receptor Positive, Her2 Negative, Advanced Breast Cancer: Case Series and Review of the Literature. Frontiers in Oncology. 12. 797157–797157. 2 indexed citations
10.
Botticelli, Andrea, Giulia Pomati, Alessio Cirillo, et al.. (2022). The role of immune profile in predicting outcomes in cancer patients treated with immunotherapy. Frontiers in Immunology. 13. 974087–974087. 12 indexed citations
11.
Mezi, Silvia, Andrea Botticelli, Giulia Pomati, et al.. (2021). Standard of Care and Promising New Agents for the Treatment of Mesenchymal Triple-Negative Breast Cancer. Cancers. 13(5). 1080–1080. 14 indexed citations
12.
Botticelli, Andrea, Alessio Cirillo, Lidia Strigari, et al.. (2021). Anti–PD-1 and Anti–PD-L1 in Head and Neck Cancer: A Network Meta-Analysis. Frontiers in Immunology. 12. 705096–705096. 67 indexed citations
13.
Botticelli, Andrea, Alessio Cirillo, Giulia Pomati, et al.. (2021). The role of opioids in cancer response to immunotherapy. Journal of Translational Medicine. 19(1). 119–119. 29 indexed citations
14.
Cerbelli, Bruna, Simone Scagnoli, Silvia Mezi, et al.. (2020). Tissue Immune Profile: A Tool to Predict Response to Neoadjuvant Therapy in Triple Negative Breast Cancer. Cancers. 12(9). 2648–2648. 18 indexed citations
15.
Botticelli, Andrea, Silvia Mezi, Giulia Pomati, et al.. (2020). Tryptophan Catabolism as Immune Mechanism of Primary Resistance to Anti-PD-1. Frontiers in Immunology. 11. 1243–1243. 34 indexed citations
16.
Nichetti, Federico, Antonio Marra, Carlo Alberto Giorgi, et al.. (2020). 337P Efficacy of everolimus plus exemestane in CDK 4/6 inhibitors-pretreated or naïve HR-positive/HER2-negative breast cancer patients: A secondary analysis of the EVERMET study. Annals of Oncology. 31. S382–S382. 5 indexed citations
17.
Gelibter, Alain, et al.. (2019). Adjuvant chemotherapy in resected colon cancer: When, how and how long?. Surgical Oncology. 30. 100–107. 55 indexed citations
18.
Grossi, Francesco, Lucio Crinò, Annamaria Catino, et al.. (2017). P3.02c-096 Use of Nivolumab in Elderly Patients with Advanced Squamous NSCLC: Results from the Italian Expanded Access Programme (EAP). Journal of Thoracic Oncology. 12(1). S1337–S1338. 2 indexed citations
19.
20.
Cortesi, Enrico, Gianluca Masi, M. Mancini, et al.. (2016). P-158 Radioembolization (SIRT) as a Consolidation Treatment in Colorectal Liver Metastases after First Line Chemotherapy: Efficacy Safety. Annals of Oncology. 27. ii47–ii47. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wentao Tian Breakdown of academic impact, for papers by Yuji Nojima Breakdown of academic impact, for papers by Roland Eid Breakdown of academic impact, for papers by Tang Qing Breakdown of academic impact, for papers by Koji Fujieda Breakdown of academic impact, for papers by Philippe Huget Breakdown of academic impact, for papers by Yida Li Breakdown of academic impact, for papers by Haiyang Chen Breakdown of academic impact, for papers by Carmen Vallejo Breakdown of academic impact, for papers by Nick B. Tsavaris
Rankless by CCL
2026